TP53 and myeloid neoplasm: Stratified analysis by environmental factors (acetaldehyde exposure or smoking) revealed their significant interactions with TP53-CHIP for myeloid neoplasms and respiratory disease (nonneoplastic respiratory disease and lung cancer) mortality (Supplementary Table S6).